Carregant...
Ginsenoside Rg2 protects cardiomyocytes against trastuzumab-induced toxicity by inducing autophagy
Trastuzumab (TZM) significantly improves the outcomes of patients with breast cancer; however, it is associated with severe cardiotoxicity. Ginsenoside Rg2 was reported to exert protective effects against myocardial injury and apoptosis in human cardiomyocytes (HCMs). However, whether ginsenoside Rg...
Guardat en:
| Publicat a: | Exp Ther Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7976377/ https://ncbi.nlm.nih.gov/pubmed/33767768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9904 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|